Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,245-2,256 of 10,592
Drug study icon
WithdrawnNCT00442923

"The Evaluation of Stimulant Withdrawal"

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Addiction, AnxietyDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Aaron J. Janowsky
Condition
Addiction, Anxiety
Other study type icon
CompletedNCT03348384

[11C]NOP-1A and Cocaine Use Disorders

This study is completed in the United States. It focuses on Addiction.

In United States
AddictionOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Addiction
Other study type icon
CompletedNCT03448016

[C-11]NOP-1A and Addiction

This study is completed in the United States. It focuses on Addiction.

In United States
AddictionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Rajesh Narendran
Condition
Addiction
Device study icon
TerminatedNCT05551195

Digital Therapeutic for depression

This study was terminated in the United States. It is testing digital Therapeutic for depression.

In United States
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 45 Years
Countries
United States
Sponsor
Woebot Health
Condition
Depression
Device study icon
CompletedNCT03888391

12 Month Open Extension of TNS for ADHD.

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In United States
ADHDDeviceFrom 8 Years to 13 Years
Countries
United States
Sponsor
James McGough
Condition
ADHD
Drug study icon
CompletedNCT00223496

12- Week Open Label Treatment of Refractory Depression in bipolarity

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT00583440

12-step Facilitation for the Dually Diagnosed

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Mental healthBehavioralOver 18 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Mental health
Drug study icon
CompletedNCT02363738

12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
University Health Network, Toronto
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.